Heparin lock flush and Glipizide drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Heparin lock flush and Glipizide. Common interactions include dehydration among females and abdominal pain among males.

The phase IV clinical study analyzes what interactions people who take Heparin lock flush and Glipizide have. It is created by eHealthMe based on reports of 9 people who take Heparin lock flush and Glipizide from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Aug, 17, 2022

9 people who take Heparin lock flush and Glipizide together, and have interactions are studied.


What is Heparin lock flush?

Heparin lock flush has active ingredients of heparin sodium. eHealthMe is studying from 570 Heparin lock flush users for its effectiveness, alternative drugs and more.

What is Glipizide?

Glipizide has active ingredients of glipizide. It is often used in diabetes. eHealthMe is studying from 57,252 Glipizide users for its effectiveness, alternative drugs and more.

Number of Heparin lock flush and Glipizide reports submitted per year:

Heparin lock flush and Glipizide drug interactions.

Common Heparin Lock Flush and Glipizide drug interactions by gender *:

female:

  1. Dehydration
  2. Alopecia
  3. Burning sensation
  4. Cellulitis
  5. Cerebrovascular accident
  6. Endocarditis
  7. Feeling hot
  8. Flushing
  9. Gait disturbance
  10. Hypoaesthesia

male:

  1. Abdominal pain
  2. Colitis
  3. Diarrhoea
  4. Dyspnoea
  5. Nausea
  6. Vomiting

Common Heparin Lock Flush and Glipizide drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Abdominal pain
  2. Alopecia
  3. Colitis
  4. Diarrhoea
  5. Dyspnoea
  6. Nausea
  7. Psychological trauma
  8. Vomiting

60+:

  1. Abdominal pain
  2. Burning sensation
  3. Myocardial infarction
  4. Nausea
  5. Paraesthesia
  6. Respiratory failure
  7. Thrombocytopenia
  8. Vision blurred
  9. Vomiting
  10. Atrial fibrillation

* Approximation only. Some reports may have incomplete information.

Do you take Heparin lock flush and Glipizide?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related publications that referenced our studies

Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Browse all drug interactions of Heparin lock flush and Glipizide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Heparin lock flush interactions:

Browse all interactions between Heparin lock flush and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Glipizide interactions:

Browse all interactions between Glipizide and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on heparin sodium and glipizide (the active ingredients of Heparin lock flush and Glipizide, respectively), and Heparin lock flush and Glipizide (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Heparin lock flush and Glipizide.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: